MAPT-derived circTau6 induces tau pathogenesis and neurodegeneration by encoding Tau variants.

Guangtong Jiang Dan-Ni Wang Lin Shao Xinru Mao Xiao-Peng Xiong Deng-Hong Zhang Win-Ning Chen Huilong Yuan Shijia Wang Jian Zhang J. Piña-Crespo Li Zhong Yun-wu Zhang Jie Zhang Huaxi Xu Ming Chen Timothy Y. Huang Xi-Lin Wu Peng Lei Ying-Jun Zhao

Jul 2026 · Molecular Psychiatry · 0 citations · 45 references

Medicine

TL;DR

Findings identify circTau6/cTau4R as a post-transcriptional mechanism that modulates tauopathy and partially recapitulated molecular signatures observed in human tauopathic brains.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Jul 2026

Tau isoform imbalance and aggregation are pathological hallmarks of X-linked dystonia-parkinsonism

It is reported that X-linked Dystonia-Parkinsonism (XDP), caused by a non-coding retrotransposon-associated repeat insertion in TAF1, involves a significant imbalance of tau isoforms and the accumulation of hyperphosphorylated, four-repeat tau in the brain.

C. J. Reyes, Aloysius Domingo, E. Penney et al. · medRxiv · 0 citations

Aug 2026

MAPT splicing modulators reduce 4R tau and rescue tauopathy phenotypes in human neurons and in a mouse model.

Treatment with splicing modulator compounds that promote MAPT exon 10 exclusion reduced 4R tau expression and decreased the accumulation of hyperphosphorylated tau (pTau) and oligomeric and insoluble tau proteoforms, thereby rescuing tau-associated neuronal toxicity.

M. Silva, Hannah Lindmeier, Paolo Pigini et al. · Science Translational Medici... · 1 citation · ⚡1

Open access Jul 2026

CELF2 promotes 4R Tau splicing via nuclear clustering and drives cognitive dysfunction in tauopathy models

Alternative splicing is a fundamental mechanism underlying protein diversity. The microtubule-associated protein tau (MAPT) undergoes age-associated alternative splicing of exon 10 to generate 3 R and 4 R isoforms, and disruption of the 4 R:3 R ratio is a central feature of tauopathies. However, the molecular mechanism...

Xin Li, Ishana Syed, Rashmi Adhikari et al. · Nature Communications · 0 citations

Sep 2026

Circ_0004801 promotes tau hyperphosphorylation and cognitive impairment in Alzheimer's disease through the miR-7688-5p/TTBK1 axis.

BackgroundAbnormal tau hyperphosphorylation is a central feature of Alzheimer's disease (AD). Tau tubulin kinase 1 (TTBK1) is a key kinase involved in tau phosphorylation, but its upstream regulatory mechanisms remain poorly understood.ObjectiveTo identify circRNAs involved in the upstream regulation of TTBK1 and eluci...

Qing-Qing Li, Jie Xiao, Guo-Rong Deng et al. · Journal of Alzheimer's Disea... · 0 citations

Review Open access Sep 2026

Therapeutic Targeting of Tauopathies: From Druggable Biology to Precision Intervention.

Tauopathies encompass a heterogeneous group of neurodegenerative disorders characterized by the transition of tau from a microtubule-stabilizing protein into pathogenic, seed-competent species. Increasing evidence has redefined tau from a descriptive pathological hallmark to a pharmacologically actionable target across...

Cheng-Jia Zhang, Jia-Liang Ma, Xin-Ruo Wu et al. · Pharmacological Research · 0 citations

Open access Aug 2026

Amplification of seeding-competent tau aggregates by PMCA in human and experimental tauopathies

Tau assemblies, associated with tauopathies, are believed to self-propagate through prion-like mechanisms in the central nervous system, driving neurodegeneration. Recently, protein seed amplification assays have emerged as highly sensitive methods for detecting trace amounts of misfolded protein assemblies across vari...

Florian Almela, M. Bélondrade, R. Caillierez et al. · Acta Neuropathologica Commun... · 0 citations